PAM
ALDR

Panagora Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Panagora Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-446
Closed -$15K – 2413
2015
Q3 		$15K Sell
446
-225
-34% -$9.57K ﹤0.01% 2184
2015
Q2 		$36K Buy
+671
New +$24.4K ﹤0.01% 2211

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Panagora Asset Management's ALDR Position: Q4 2015 in Review

Panagora Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2015, closing a stake of 446 shares — an estimated $15K sold.

Panagora Asset Management first reported a position in ALDR in Q2 2015 and held it in 2 quarters. The position peaked at $36K in Q2 2015. 134 funds tracked by Wall St. Rank hold ALDR as of Q4 2015.

  • Panagora Asset Management reported no remaining Alder Biopharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Panagora Asset Management sold 446 Alder Biopharmaceuticals shares in Q4 2015, an estimated $15K.
  • Panagora Asset Management first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Panagora Asset Management's Alder Biopharmaceuticals position peaked at $36K in Q2 2015.
  • 134 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2015.

Based on Panagora Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.